Raj Gandesha | White & Case LLP International Law Firm, Global Law Practice
Raj Gandesha
Raj Gandesha

Raj Gandesha

Partner, New York

T +1 212 819 8975

T +1 212 819 8200

E rgandesha@whitecase.com

in LinkedIn profile

Major companies look to Raj Gandesha for his counsel on complex intellectual property, antitrust and commercial litigations.

Overview

Raj represents clients in complex intellectual property, antitrust and commercial litigations. He has worked on high-profile, 'bet the company' cases that have helped shape IP and antitrust law.

Raj also advises clients with respect to personal data privacy matters, including cross-border transfers of personal data, security breach notification issues and Internet privacy policies.

His client list is varied and international in scope and includes companies operating in the pharmaceutical, oil, IT, consumer health, entertainment and financial services industries. He regularly represents both national and multinational businesses with cross-border interests.

Bars and Courts

  • New York State Bar
  • US District Court for the Southern District of New York
  • US District Court for the Eastern District of New York

Education

  • JD, University of Toronto Faculty of Law
  • BA, (First Class Hons.), Politics, Philosophy and Economics, Oxford University

Languages

  • English

Experience

Pfizer, 2014–ongoing

Raj is representing Pfizer in federal class action antitrust litigations with respect to Celebrex, accusing the company of delaying entry of generic competition for Celebrex through alleged fraud on the US patent office and sham patent litigation. In re Celebrex Antitrust Litigation (E.D. Va.).

Pfizer, 2011–ongoing

Raj is representing Pfizer in federal consolidated class action antitrust litigations and a state court action brought by the West Virginia Attorney General with respect to Lipitor, which accused the company of delaying entry of generic competition for Lipitor through alleged fraud on the US patent office and sham patent litigation, a sham FDA citizen petition and a reverse payment settlement agreement. In re Lipitor Antitrust Litigation (D.N.J.); State of West Virginia v. Pfizer, Inc., et al. (Cir. Ct., Mason Cty., W.V.).

Pfizer, 2011–ongoing

Raj is representing Pfizer in federal class action antitrust litigations with respect to Effexor XR, accusing the company of delaying entry of generic competition for Effexor XR through alleged fraud on the US patent office, sham patent litigation and a reverse payment settlement agreement. In re Effexor XR Antitrust Litigation (D.N.J.).

Sandoz, 2009–present

Raj has represented Sandoz in multiple state and federal actions alleging false claims act, common law fraud and consumer protection claims based on allegations that drug manufacturers reported inaccurate pricing benchmarks that allegedly caused state Medicaid agencies to overpay for prescription drugs provided to Medicaid beneficiaries.